Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$169,336,607
+$23,695,082 QoQ
Shares Held
672,932
+0.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#179
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. ABBV ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
544,998 | $653,687,004 | |
| 2 | JNJ |
Johnson & Johnson
|
1,322,168 | $335,791,005 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,264,357 | $245,712,249 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,644,035 | $207,707,380 | |
| 5 | PFE |
Pfizer Inc
|
8,327,265 | $200,520,541 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
672,932 | $169,336,607 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,131,286 | $145,370,250 | |
| 8 | AMGN |
Amgen Inc
|
382,676 | $138,574,632 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $169,336,607 | 672,932 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $145,641,525 | 669,647 | Shares | Defined | 2026-05-07 | |
| 2025-09-30 | $261,526,976 | 1,129,511 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $205,612,944 | 1,107,709 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $231,335,221 | 1,104,120 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $203,741,933 | 1,146,550 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $215,657,836 | 1,092,049 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $117,119,858 | 682,835 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $151,280,120 | 830,753 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $166,165,186 | 1,072,241 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $152,004,232 | 1,019,752 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $120,327,092 | 893,098 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $170,600,006 | 1,070,465 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $225,154,243 | 1,393,195 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $192,280,385 | 1,432,683 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $186,787,196 | 1,219,556 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $124,859,715 | 770,216 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $76,703,286 | 566,494 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $39,928,727 | 370,156 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $44,550,808 | 395,515 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $41,559,400 | 384,027 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $50,659,341 | 472,789 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $57,096,942 | 651,866 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $132,291,363 | 1,347,437 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $56,121,400 | 736,598 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||